ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
1,625
0,115
(7,62%)
À la fermeture: 02 Décembre 10:00PM
1,625
0,00
( 0,00% )
Après les heures de négociation: 10:30PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
1,625
Prix Achat
1,60
Prix Vente
1,70
Volume échangé
46 147
1,58 Fourchette du Jour 1,70
0,50 Plage de 52 semaines 4,95
Cap du marché
Clôture Veille
1,51
Ouverture
1,61
Dernière Transaction
300
@
1.6011
(formt)
Dernière heure de transaction
22:01:45
Volume financier
US$ 75 103
VWAP
1,6275
Volume moyen (3 m)
78 720
Actions en circulation
112 824 183
Rendement du Dividende
-
Ratio Cours sur Bénéfices
4,30
Bénéfice par action (BPA)
0,38
Chiffre d'affairess
409,92M
Bénéfice net
42,54M

À propos de Procaps Group SA

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardio... Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. Show more

Secteur
Medicinal Chems,botanicl Pds
Industrie
Medicinal Chems,botanicl Pds
Siège social
Luxembourg City, Luxembourg, Lux
Fondé
-
Procaps Group SA est coté dans le secteur Medicinal Chems,botanicl Pds de la NASDAQ avec le ticker PROC. Le dernier cours de clôture d'Procaps était de US$1,51. Au cours de la dernière année, les actions de Procaps ont été négociées dans une fourchette de prix de US$ 0,50 à US$ 4,95.

Procaps compte actuellement 112 824 183 actions en circulation. La capitalisation boursière d'Procaps est de US$170,36 million. Procaps a un ratio cours/bénéfice (ratio PE) de 4.30.

PROC Dernières nouvelles

Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing

MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, on November 13, 2024, the Company...

Procaps Issues Shareholder Letter Update

MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Issues Shareholder Letter Update

MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Issues Shareholder Letter

MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Group Announces New Chairman

Ruben Minski decides to step down as Executive Chairman and José Minski is appointed as new Chairman of the Board Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...

Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F

Procaps Group (Nasdaq: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has received a letter from the Nasdaq...

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file...

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file...

Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it is conducting a process to explore...

Procaps Issues Shareholder Letter from New CEO

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued a letter to shareholders from Jose Vieira, CEO of...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.65567.52577319590.972.190.972131481.50589108CS
4-0.205-11.20218579231.832.190.52207051.14768086CS
12-0.355-17.92929292931.982.35010.5787201.23105628CS
26-1.215-42.78169014082.842.880.5392351.29447317CS
52-1.025-38.6792452832.654.950.5317452.07739968CS
156-8.065-83.23013415899.6910.490.5259864.67802454CS
260-6.785-80.6777645668.4111.980.5310495.75061466CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CTORCitius Oncology Inc
US$ 1,58
(54,90%)
4,83M
JANXJanux Therapeutics Inc
US$ 62,09
(54,53%)
976,26k
SHIMShimmick Corporation
US$ 3,91
(39,64%)
1,74M
CRDOCredo Technology Group Holding Ltd
US$ 63,38
(32,59%)
789,37k
VIRVir Biotechnology Inc
US$ 10,1899
(25,03%)
290,44k
GELSGelteq Ltd
US$ 2,85
(-25,40%)
200,44k
APMAptorum Group Ltd
US$ 0,6401
(-24,25%)
341,82k
INDIindie Semiconductor Inc
US$ 4,40
(-16,67%)
243,67k
OMEXOdyssey Marine Exploration Inc
US$ 0,6302
(-15,43%)
1,2M
SILOSilo Pharma Inc
US$ 0,90
(-14,29%)
11,09k
CTORCitius Oncology Inc
US$ 1,58
(54,90%)
4,83M
INTCIntel Corporation
US$ 23,91
(-0,08%)
2,61M
CLSKCleanSpark Inc
US$ 13,72
(-5,51%)
2,52M
TSLATesla Inc
US$ 351,25
(-1,64%)
2,45M
KITTNauticus Robotics Inc
US$ 1,32
(17,86%)
2,2M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock